Geode Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$82.9M Buy
1,311,253
+24,085
+2% +$1.52M 0.01% 1138
2025
Q1
$68.2M Buy
1,287,168
+31,369
+2% +$1.66M 0.01% 1192
2024
Q4
$70.3M Sell
1,255,799
-389
-0% -$21.8K 0.01% 1212
2024
Q3
$65.8M Buy
1,256,188
+3,499
+0.3% +$183K 0.01% 1260
2024
Q2
$51.4M Buy
1,252,689
+71,984
+6% +$2.96M ﹤0.01% 1345
2024
Q1
$51.2M Buy
1,180,705
+61,576
+6% +$2.67M ﹤0.01% 1336
2023
Q4
$51.5M Buy
1,119,129
+74,072
+7% +$3.41M 0.01% 1332
2023
Q3
$24M Buy
1,045,057
+71,707
+7% +$1.64M ﹤0.01% 1710
2023
Q2
$16.1M Buy
973,350
+500,589
+106% +$8.25M ﹤0.01% 2003
2023
Q1
$8.43M Buy
472,761
+14,251
+3% +$254K ﹤0.01% 2364
2022
Q4
$13.4M Buy
458,510
+70,398
+18% +$2.05M ﹤0.01% 2058
2022
Q3
$9.51M Sell
388,112
-11,682
-3% -$286K ﹤0.01% 2299
2022
Q2
$1.66M Sell
399,794
-341,095
-46% -$1.42M ﹤0.01% 3185
2022
Q1
$8.54M Buy
740,889
+26,861
+4% +$309K ﹤0.01% 2458
2021
Q4
$7.13M Buy
714,028
+46,370
+7% +$463K ﹤0.01% 2676
2021
Q3
$8.72M Sell
667,658
-17,245
-3% -$225K ﹤0.01% 2552
2021
Q2
$13.4M Buy
684,903
+61,341
+10% +$1.2M ﹤0.01% 2256
2021
Q1
$13.3M Buy
623,562
+135,115
+28% +$2.87M ﹤0.01% 2156
2020
Q4
$14.5M Sell
488,447
-3,232
-0.7% -$96.1K ﹤0.01% 1912
2020
Q3
$10.7M Buy
491,679
+14,929
+3% +$323K ﹤0.01% 1899
2020
Q2
$10.6M Buy
476,750
+33,493
+8% +$747K ﹤0.01% 1897
2020
Q1
$6.75M Buy
443,257
+45,382
+11% +$691K ﹤0.01% 1971
2019
Q4
$9.14M Buy
397,875
+80,602
+25% +$1.85M ﹤0.01% 2077
2019
Q3
$6.85M Buy
317,273
+4,737
+2% +$102K ﹤0.01% 2193
2019
Q2
$6.88M Buy
312,536
+60,519
+24% +$1.33M ﹤0.01% 2186
2019
Q1
$6.91M Buy
252,017
+18,123
+8% +$497K ﹤0.01% 2133
2018
Q4
$6.29M Buy
233,894
+54,247
+30% +$1.46M ﹤0.01% 2075
2018
Q3
$5.24M Buy
179,647
+88,819
+98% +$2.59M ﹤0.01% 2330
2018
Q2
$2.84M Sell
90,828
-28,530
-24% -$892K ﹤0.01% 2656
2018
Q1
$2.38M Sell
119,358
-4,437
-4% -$88.3K ﹤0.01% 2671
2017
Q4
$3.6M Buy
+123,795
New +$3.6M ﹤0.01% 2412